Patient Selection for First Line Therapy in Stage 4 Melanoma

from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE

Dr. Vernon Sondak discusses current patient treatment standards, including using immune therapy before targeted therapy in unresectable stage 4 disease.

Episode metadata supplied by the publisher feed · Published May 22, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Patient Selection for First Line Therapy in Stage 4 Melanoma

0:00 6:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?

This episode is 6 minutes long.

When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?

This episode was published on May 22, 2023.

Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!